In the CRoME Research Lab, Associate Professor Olufunmilola Abraham and alum Jenny Li develop an educational tool to enable pharmacists to partner with parents in addressing teen vaping.
Research
Professor Emeritus Bonnie Svarstad Wins Wiederholt Prize for Record 3rd Time
The Journal of the American Pharmacists Association honors Professor Emeritus Bonnie Svarstad’s paper exploring effective interventions for Black patients with hypertension.
Nano-Drugs on Bacteria Could Target Difficult-to-Treat Pancreatic Cancer
Employing bacteria to infiltrate that cancerous fortification and deliver drugs could aid treatment for pancreatic cancer, according to newly published findings from a team of University of Wisconsin–Madison researchers.
New Nanomaterial Could Advance Neurodegenerative Disease Treatments
A newly developed nanomaterial that mimics the behavior of proteins could be an effective tool for treating Alzheimer’s and other neurodegenerative diseases.
An Opioid Safety Game-Changer
Associate Professor Olufunmilola Abraham’s opioid safety video game reaches the point of prescription: emergency departments.
Assistant Professor Quanyin Hu Honored as Vilas Associate
A competitive Vilas Associates award recognizes Assistant Professor Quanyin Hu’s innovations in cell therapy research and fuels more development.
Designing a Better Approach to Monitor Cancer
Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.
Leading Lab in Photos: Behind the Scenes in the Wenthur Lab
See the people, processes, and equipment behind Assistant Professor Cody Wenthur’s exploration into psychoactive substances.
Community Pharmacies Step Up to Meet Health Needs of Underserved Areas
A study led by School of Pharmacy faculty and students examines how Wisconsin pharmacies expand services but struggle with staffing, reimbursement.
Study Identifies Promising Target for Treating Inflammatory Bowel Disease and Colitis-Induced Colorectal Cancers
Assistant Professor Ting Fu and collaborators have identified a promising new target for treatments that could help the millions of people worldwide who suffer from inflammatory bowel disease and related colorectal cancers.